Differential Structural Remodeling of the Left‐Atrial Posterior Wall in Patients Affected by Mitral Regurgitation with or Without Persistent Atrial Fibrillation: A Morphological and Molecular Study
- 28 September 2011
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 23 (3), 271-279
- https://doi.org/10.1111/j.1540-8167.2011.02187.x
Abstract
Atrial fibrillation (AF) in mitral regurgitation (MR) is a complex disease where multiple factors may induce left-atrial structural remodeling (SR). We explored the differential SR of the left-atrial posterior wall (LAPW) of patients affected by MR with or without persistent AF, and the expression of key proteins involved in its pathogenesis. Light microscopy of LAPW samples from 27 patients with MR and persistent AF (group 1), 33 with MR in sinus rhythm (group 2), and 15 autopsy controls (group 3) was used to measure myocyte diameter, percentage of myocytolytic myocytes, interstitial fibrosis, and capillary density; RT-PCR and Western blotting were used to assess the mRNA and protein levels of SOD-1, SOD-2, HO-1, calpain, MMP-2, MMP-9, TIMP-1, TIMP-2, and VEGF; immunofluorescence was used to locate these proteins. Myocyte diameter was similar in groups 1 and 2, but larger than controls. Compared to group 2, group 1 had more myocytolytic myocytes (20.8 ± 5.6% vs 14.7 ± 4.5%; P < 0.0001), increased interstitial fibrosis (10.4 ± 5.1% vs 7.5 ± 4.2%; P < 0.05), and decreased capillary density (923 ± 107 No/mm(2) vs 1,040 ± 100 No/mm(2); P < 0.0001). All of the proteins were more expressed in groups 1 and 2 than in controls. The protein and mRNA levels of SOD-1, SOD-2, MMP-2, and MMP-9 were higher in group 1 than in group 2. The LAPW of MR patients with or without AF shows considerable SR. The former has more severe histopathological changes and higher levels of proteins involved in SR, thereby reaching a threshold beyond which the sinus impulse cannot normally activate atrial myocardium.Keywords
This publication has 38 references indexed in Scilit:
- Physiologic and Pathophysiologic Role of Calpain: Implications for the Occurrence of Atrial FibrillationCardiovascular Therapeutics, 2010
- Vascular endothelial growth factor (VEGF)-A: Role on cardiac angiogenesis following myocardial infarctionMicrovascular Research, 2010
- Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic PotentialAntioxidants and Redox Signaling, 2010
- Update on the Association of Inflammation and Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2010
- Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillationJournal of Molecular and Cellular Cardiology, 2008
- Matrix Metalloproteinase Inhibition Attenuates Atrial Remodeling and Vulnerability to Atrial Fibrillation in a Canine Model of Heart FailureJournal of Cardiac Failure, 2008
- Progress in matrix metalloproteinase researchMolecular Aspects of Medicine, 2008
- Isolated Atrial Microvascular Dysfunction in Patients With Lone Recurrent Atrial FibrillationJournal of the American College of Cardiology, 2008
- Atrial fibrillation complicating the course of degenerative mitral regurgitation: Determinants and long-term outcomeJournal of the American College of Cardiology, 2002
- Chronic hibernating myocardium: Interstitial changesMolecular and Cellular Biochemistry, 1995